A detailed history of Globeflex Capital L P transactions in Veracyte, Inc. stock. As of the latest transaction made, Globeflex Capital L P holds 9,304 shares of VCYT stock, worth $381,370. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,304
Holding current value
$381,370
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$21.0 - $35.25 $195,384 - $327,966
9,304 New
9,304 $316,000
Q1 2023

May 12, 2023

BUY
$20.58 - $27.89 $114,218 - $154,789
5,550 Added 86.72%
11,950 $266,000
Q4 2022

Feb 10, 2023

BUY
$15.31 - $29.94 $97,984 - $191,616
6,400 New
6,400 $151,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.93B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.